Pyrazolam

From Wikipedia, the free encyclopedia
Pyrazolam
Systematic (IUPAC) name
8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
Clinical data
Legal status Unlicensed
Routes Oral, Sublingual, rectal, Intravenous
Pharmacokinetic data
Half-life 17 hours ?
Identifiers
CAS number 39243-02-2
ATC code ?
PubChem CID 12562545
Chemical data
Formula C16H12BrN5 
Mol. mass 354.204 g/mol

Pyrazolam is a benzodiazepine derivative originally developed by a team lead by Leo Sternbach at Hoffman-La Roche in the 1970s,[1] and subsequently "rediscovered" and sold as a designer drug starting in 2012.[2] It is mainly an anxiolytic, but it has also shown anticonvulsant and hypnotic effects and has structural similarity to alprazolam.[3] Pyrazolam has no active metabolites[4] and has activity 12x stronger than diazepam while causing little ataxia and sedation. It is most selective for the α2 and α3 receptor subtypes[5] which means it causes less ataxia and sedation when taken at therapeutic doses.

Binding data (GABA):[citation needed]

α1 3.84±0.25
α2 1.31±0.19
α3 1.48±0.21
α5 3.72±0.32


References

  1. US Patent 3954728 Preparation of triazolo benzodiazepines and novel compounds
  2. Moosmann, B.; Hutter, M.; Huppertz, L. M.; Ferlaino, S.; Redlingshöfer, L.; Auwärter, V. (2013). "Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine". Forensic Toxicology 31 (2): 263. doi:10.1007/s11419-013-0187-4. 
  3. 6-Phenyl-4H-s-triazolo[4,3-a][l,4]benzodiazepines Which Have Central Nervous System Depressant Activity J. Med. CHem Vol 14, No 11 Pages 1078-1081
  4. Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine - Forensic Toxicology July 2013, Volume 31, Issue 2, pp 263-271
  5. 6-Aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines. Influence of 1-substitution on pharmacological activity - J. Med. Chem., 1979, 22 (11), pp 1390–1398


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.